Profile
Abdul Khan, Ph.D., is a Director, Biologics, Deerfield Discovery and Development, and joined the Firm in 2022.
Prior to Deerfield, Dr. Khan was a Director, Protein Engineering at Molecular Templates for a year.
Before this, he was most recently Senior Associate Director, Protein and Cell Line Engineering for Tri-Institutional Therapeutics Discovery Institute (Tri-I TDI), where he worked for more than five years.
Dr. Khan holds a B.S.
in Chemistry, Zoology, and Botany, an M.S.
in Zoology, a Master of Philosophy in Molecular Biology from Punjab University, Pakistan, and a Ph.D.
in Natural Sciences from University of Vienna, Austria.
Abdul Khan active positions
| Companies | Position | Start |
|---|---|---|
Deerfield Management Co. LP (Private Equity)
Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management invests in both private and public companies located in the United States. The firm targets companies operating in the fields of diagnostic, digital health, life science, medical device, and health care services. It provides financing for pre-seed, seed, early, later and growth stage capital requirements. | Director/Board Member | 2022-08-31 |
Former positions of Abdul Khan
| Companies | Position | End |
|---|---|---|
| MOLECULAR TEMPLATES, INC. | Director/Board Member | 2022-08-31 |
Training of Abdul Khan
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
University of Vienna
University of Vienna Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of the Punjab
University of the Punjab Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Deerfield Management Co. LP (Private Equity)
Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management invests in both private and public companies located in the United States. The firm targets companies operating in the fields of diagnostic, digital health, life science, medical device, and health care services. It provides financing for pre-seed, seed, early, later and growth stage capital requirements. | Finance |
Molecular Templates, Inc.
Molecular Templates, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company | Commercial Services |
- Stock Market
- Insiders
- Abdul Khan
















